LEO Laboratories Limited
34Patents
33Active
34Granted
53Portfolio score
Filing activity: Dec 2, 2005 → Jun 9, 2016 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD731325S1 | Packaging | General | 71 | Active |
| US8377919B2 | Therapeutic compositions | Human Necessities | 9 | Active |
| US8278292B2 | Therapeutic compositions | Human Necessities | 9 | Active |
| US8372827B2 | Therapeutic compositions | Human Necessities | 8 | Active |
| US8372828B2 | Therapeutic compositions | Human Necessities | 8 | Active |
| US8735375B2 | Therapeutic compositions | Human Necessities | 7 | Active |
| US8901356B2 | Method of producing ingenol-3-angelate | Emerging Cross-Sectional Technologies | 7 | Active |
| US8536163B2 | Therapeutic compositions | Human Necessities | 6 | Active |
| US8716271B2 | Therapeutic compositions | Human Necessities | 6 | Active |
| US9314458B2 | Topical use of ingenol-3-angelate or a salt thereof to treat skin cancer | Emerging Cross-Sectional Technologies | 5 | Active |
| US9416084B2 | Method of producing ingenol-3-angelate | Emerging Cross-Sectional Technologies | 4 | Active |
| US9676698B2 | Method of producing ingenol-3-angelate | Emerging Cross-Sectional Technologies | 4 | Active |
| US8653133B2 | Crystalline ingenol mebutate | Emerging Cross-Sectional Technologies | 2 | Active |
| US8106092B2 | Treatment of solid cancers | Human Necessities | 2 | Expired |
| US9402823B2 | Ingenols for treating seborrheic keratosis | Human Necessities | 1 | Active |
| US9102687B2 | Ingenol-3-acylates III and ingenol-3-carbamates | Chemistry; Metallurgy | 1 | Active |
| US9422309B2 | 3-O-heteroaryl-ingenol | Chemistry; Metallurgy | 1 | Active |
| US9833428B2 | Therapeutic compositions | Human Necessities | 0 | Active |
| US9833429B2 | Therapeutic compositions | Human Necessities | 0 | Active |
| US9409931B1 | 3-O-acyl-ingenol analogues | Chemistry; Metallurgy | 0 | Active |
| US9388124B2 | Ingenol-3-acylates I | Chemistry; Metallurgy | 0 | Active |
| US9656945B2 | 3-acyl-ingenols II | Chemistry; Metallurgy | 0 | Active |
| US9526714B2 | Method for treating skin lesions with ingenol mebutate | Human Necessities | 0 | Active |
| US9861603B2 | Therapeutic compositions | Human Necessities | 0 | Active |
| US9603822B2 | Therapeutic compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.